Cleared Special

K132701 - PRIMI SUPPORT CATHETER

K132701 is an FDA 510(k) clearance for PRIMI SUPPORT CATHETER, manufactured by Thermopeutix, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Special 510(k) pathway after a 28-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2013
Decision
28d
Days
Class 2
Risk

K132701 is an FDA 510(k) clearance for the PRIMI SUPPORT CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Thermopeutix, Inc. (San Diego, US). The FDA issued a Cleared decision on September 26, 2013 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Thermopeutix, Inc. devices

FDA 510(k) Submission Details - K132701

510(k) Number K132701 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2013
Decision Date September 26, 2013
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 655
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K132701.
5F & 6F LAUNCHER GUIDE CATHETER, 5F SHERPA ACTIVE NX GUIDE CATHETER, 6F Z4 GUIDING CATHETER
K132673 · Medtronic, Inc. · Oct 2013
MODIFIED FLOWGATE BALLOON GUIDE CATHETER
K131492 · Concentric Medical, Inc. · Oct 2013
VOLCANO PREVIEW FORWARD-LOOKING IVUS SYSTEM
K132659 · Volcano Corporation · Sep 2013
CONCIERGE GUIDING CATHETER
K132409 · Merit Medical Systems, Inc. · Aug 2013
SELECTRA ACCESSORY KIT, SELECTRA SLITTER TOOL
K131978 · Biotronik, Inc. · Aug 2013
AMPLATZER TORQ VUE LP DELIVERY SYSTEM
K131063 · St Jude Medical · Aug 2013